RE: NT TO SELL ALL MORNING6 Nov 2020 13:55
Natham, you are very childish Labelling me a de-ramper. Obviously you do not like my posts, although less than 2 weeks ago you yourself were shouting pump & dump. Interesting how you have changed your stance and you don’t call other posters ‘rampers’ for claiming multibag and 50p coming when clearly the market would disagree, the SP is re-tracing, and for obvious reason.
Rather than me ‘de-ramping’ let me state some facts that shrewd investors may like to consider ...... you don’t have to read any further.
29th May agreement signed with NPH ........ 5 months on, no commercial contracts
3rd July pilot agreement with Afrik- ID ...... 4 months on, no commercial contracts
Government roll out mass testing, 3 companies products have been tested ........ CTEA products not chosen by the government for the trial in Liverpool
With such a need in the world for a ‘viable’ solution to help control Covid - 19, CTEA claiming they have a solution, why have they no sales to date.
Involved with Newcastle Premier Heath, so in the ‘system’, but still no sales .......
Afrik-Id have trialled our product for 4 months ....... 4 months !! And still nothing.
Afrik ID have signed only a MOU, not legally binding, and will now trial the CTEA / BHA package, how many months do you think they will trial this for ......... !
Only reason the recent rise from 2.2p the past week or so all based on possibility of U.K. Government contract ....... I would say people starting to realise those hopes have passed.
Give this another week without news and I think more will start to wake up, smell the coffee and realise your ‘multibag’ 50p a share on government contract is not going to come to fruition.
Longer term, I have hope for CTEA. My posting history is there to be seen. I have hopes for CTEA with their Covid-ID app due to Brexit, and the possibility of a need for their product by the summer next year.
Do I think the companies SP is worth today’s 3.5p, no not a chance. Back to 2.2 - 2.3p and I will have a small punt on the possibility of the Cov-ID gaining traction next year.
‘Deramper’ ....... call me what you like. Market will do the talking